Serum levels of CA 125 and TPS during treatment of ovarian cancer.
Van Dalen A, Favier J, Baumgartner L, Hasholzner U, De Bruijn H, Dobbler D, Dombi VH, Fink D, Giai M, McGing P, Harlozinska A, Kainz C, Markowska J, Molina R, Sturgeon C, Bowman A, Einarsson R.
Van Dalen A, et al. Among authors: sturgeon c.
Anticancer Res. 2000 Nov-Dec;20(6D):5107-8.
Anticancer Res. 2000.
PMID: 11326677